TFX

+ Watchlist + Portfolio

Teleflex Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $135.86
52-Week Range: $100.18 – $145.00
Market Cap: $5.72B
P/E (TTM): —
EPS (TTM): -0.53
Dividend Yield: 1.00%

Advanced Metrics

Price/Book: 1.97
PEG Ratio: 0.16
Return on Equity: -0.70%
Return on Assets: 1.75%
Gross Margin: 55.11%
Operating Margin: 14.44%
Profit Margin: -45.76%
Current Ratio: 2.60
Debt/Equity: 1.01
Total Debt: $2.94B
Free Cash Flow: $179.54M
Revenue Growth: 28.90%
Earnings Growth: -17.30%
Enterprise Value: $8.37B

TFX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$2.79B	$1.71B	$1.70B	$1.99B
Cost of Revenue	$1.26B	$672.33M	$662.16M	$871.96M
Gross Profit	$1.53B	$1.04B	$1.04B	$1.12B
Research & Development	$153.82M	$113.63M	$109.02M	$144.78M
Selling, General & Admin	$863.75M	$622.74M	$674.52M	$720.17M
Operating Expenses	$1.02B	$736.37M	$783.54M	$864.95M
Operating Income	$513.52M	$303.75M	$253.85M	$255.80M
EBITDA	$730.77M	$418.51M	$271.34M	$302.51M
Pretax Income	$445.92M	$185.39M	$26.29M	$24.55M
Income Tax	$83.00M	$41.87M	-$30.90M	-$33.98M
Net Income	$363.14M	$356.33M	$69.67M	-$905.64M
Diluted EPS	7.68	7.53	1.48	-20.30
Diluted Shares	47.31M	47.30M	47.09M	44.72M

TFX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$292.03M	$222.85M	$247.85M	$378.56M
Receivables	$408.83M	$443.47M	$226.73M	$345.58M
Inventory	$578.51M	$626.22M	$306.77M	$404.39M
Current Assets	$1.41B	$1.41B	$1.47B	$1.94B
Total Assets	$6.93B	$7.53B	$7.10B	$6.95B
Current Liabilities	$581.49M	$606.75M	$649.36M	$762.03M
Long-Term Debt	$1.62B	$1.73B	$1.56B	$2.54B
Total Debt	$1.83B	$1.93B	$1.74B	$2.73B
Total Liabilities	$2.91B	$3.09B	$2.82B	$3.82B
Retained Earnings	$3.82B	$4.11B	$4.12B	$3.15B
Shareholders' Equity	$4.02B	$4.44B	$4.28B	$3.12B
Working Capital	$829.49M	$800.66M	$821.76M	$1.18B
Net Debt	$1.42B	$1.59B	$1.41B	$2.26B

TFX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$342.14M	$510.64M	$635.74M	$340.68M
Capital Expenditure	-$79.19M	-$46.42M	-$90.44M	-$95.24M
Free Cash Flow	$262.95M	$464.22M	$545.30M	$245.44M
Depreciation & Amortisation	$230.59M	$148.10M	$161.53M	$177.74M
Stock-Based Compensation	$27.22M	$27.30M	$25.96M	$25.70M
Investing Cash Flow	-$257.94M	-$621.23M	-$99.36M	-$849.19M
Financing Cash Flow	-$217.51M	$38.54M	-$421.93M	$611.54M
Dividends Paid	-$63.79M	-$63.90M	-$63.54M	-$60.27M
Share Repurchases	$0.00	$0.00	-$200.00M	-$300.00M
Net Change in Cash	-$133.31M	-$72.05M	$114.45M	$103.03M

TFX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$414.26M	$780.89M	$913.02M	-$401.87M	$548.26M
Cost of Revenue	$158.83M	$349.80M	$461.38M	-$250.45M	$240.84M
Gross Profit	$255.43M	$431.08M	$451.64M	-$151.41M	$307.43M
Research & Development	$25.30M	$38.52M	$57.23M	$12.63M	$44.39M
Selling, General & Admin	$152.91M	$215.08M	$281.76M	$614.00K	$226.01M
Operating Expenses	$178.21M	$253.60M	$338.99M	$13.24M	$270.40M
Operating Income	$77.22M	$177.48M	$112.65M	-$164.65M	$37.03M
EBITDA	$115.91M	$251.38M	-$328.81M	$247.07M	$75.63M
Pretax Income	$58.75M	$135.25M	-$438.58M	$218.94M	-$3.83M
Income Tax	$6.42M	$12.66M	-$29.70M	-$30.78M	$1.01M
Net Income	$95.00M	$122.58M	-$408.89M	-$714.33M	-$8.15M
Diluted EPS	2.07	2.77	-9.24	-16.15	-0.18
Diluted Shares	45.93M	44.33M	44.24M	44.24M	44.26M

TFX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$284.12M	$253.70M	$354.00M	$378.56M	$309.41M
Receivables	$464.52M	$513.81M	$592.65M	$345.58M	$365.53M
Inventory	$643.97M	$693.69M	$802.47M	$404.39M	$380.86M
Current Assets	$1.54B	$1.72B	$1.99B	$1.94B	$1.86B
Total Assets	$7.16B	$7.38B	$7.87B	$6.95B	$6.78B
Current Liabilities	$675.91M	$716.15M	$773.03M	$762.03M	$728.05M
Long-Term Debt	$1.81B	$1.80B	$2.57B	$2.54B	$2.51B
Total Debt	$2.00B	$2.00B	$2.77B	$2.73B	$2.69B
Total Liabilities	$3.07B	$3.13B	$4.05B	$3.82B	$3.70B
Retained Earnings	$4.20B	$4.30B	$3.88B	$3.15B	$3.13B
Shareholders' Equity	$4.10B	$4.24B	$3.82B	$3.12B	$3.08B
Working Capital	$863.00M	$1.01B	$1.21B	$1.18B	$1.13B
Net Debt	$1.62B	$1.65B	$2.32B	$2.26B	$2.31B

TFX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$73.09M	$7.74M	$107.63M	$152.21M	$49.02M
Capital Expenditure	-$24.13M	-$40.51M	-$29.95M	-$651.00K	-$18.79M
Free Cash Flow	$48.96M	-$32.77M	$77.69M	$151.56M	$30.23M
Depreciation & Amortisation	$38.62M	$94.42M	$77.92M	-$33.23M	$53.74M
Stock-Based Compensation	$6.63M	$8.14M	$8.03M	$2.90M	$6.74M
Investing Cash Flow	-$28.79M	-$30.49M	-$767.50M	-$22.41M	-$84.00M
Financing Cash Flow	-$59.52M	-$23.67M	$756.34M	-$61.61M	-$44.98M
Dividends Paid	-$15.19M	-$15.03M	-$15.02M	-$15.03M	-$15.05M
Share Repurchases	-$300.00M	-$1.89M	$0.00	$0.00	$0.00
Net Change in Cash	-$15.22M	-$46.41M	$96.47M	$68.19M	-$79.96M

Market Snapshot

About

Teleflex is a global provider of medical technologies designed to improve the health and quality of patient care. The company manufactures and distributes single-use medical devices for critical care, surgical applications, interventional cardiology, and urology, serving hospitals and healthcare providers worldwide.